{"id": "1356588526842875904", "creation": 1612270883.0, "user_id": "1077251646953013248", "social_network": "twitter", "nsfw": true, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 0, "quote_count": 0}}, "text": "via @franceinfo : #COVID_19 NEW\u2014Interim analysis of Russian #COVID19 #vaccine phase 3 trial involving nearly 20,000 participants suggests a two-dose regimen has an efficacy of 91.6% against sympt\u2026 https://t.co/XivFMSokU8", "first_save": 1634559108.199414, "hashtags": ["#COVID_19", "#COVID19", "#VACCINE"]}